Literature DB >> 1850739

Cytochalasin B as a probe of protein structure and substrate recognition by the galactose/H+ transporter of Escherichia coli.

M T Cairns1, T P McDonald, P Horne, P J Henderson, S A Baldwin.   

Abstract

Cytochalasin B is a potent inhibitor of mammalian passive glucose transporters. The recent demonstration of sequence similarities between these proteins and several bacterial proton-linked sugar transporters suggested that cytochalasin B might be a useful tool for investigation of the galactose/H+ symport protein (GalP) of Escherichia coli. Equilibrium binding studies using membranes from a GalP-constitutive (GalPc) strain of E. coli revealed a single set of high affinity binding sites for cytochalasin B with a Kd of 0.8-2.2 microM. Binding was inhibited by D-glucose, but not by L-glucose. UV irradiation of the membranes in the presence of [4-3H]cytochalasin B photolabeled principally a protein of apparent Mr 38,000, corresponding to the GalP protein. Labeling was inhibited by greater than 80% in the presence of 500 mM D-glucose or D-galactose, the major substrates of the GalP system. The extent of inhibition of photolabeling by different sugars and sugar analogues showed that the substrate specificity of GalP closely resembles that of the mammalian passive glucose transporters. Structural similarity to the latter was revealed by tryptic digestion of [4-3H]cytochalasin B-photolabeled GalP, which yielded a radiolabeled fragment of apparent Mr 17,000-19,000, similar to that previously reported for the human erythrocyte glucose transporter.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1850739

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Kinetics and thermodynamics of the binding of forskolin to the galactose-H+ transport protein, GalP, of Escherichia coli.

Authors:  G E Martin; N G Rutherford; P J Henderson; A R Walmsley
Journal:  Biochem J       Date:  1995-05-15       Impact factor: 3.857

2.  Determinants of ligand binding affinity and cooperativity at the GLUT1 endofacial site.

Authors:  Trista Robichaud; Antony N Appleyard; Richard B Herbert; Peter J F Henderson; Anthony Carruthers
Journal:  Biochemistry       Date:  2011-03-25       Impact factor: 3.162

3.  Molecular dissection of membrane-transport proteins: mass spectrometry and sequence determination of the galactose-H+ symport protein, GalP, of Escherichia coli and quantitative assay of the incorporation of [ring-2-13C]histidine and (15)NH(3).

Authors:  Henrietta Venter; Alison E Ashcroft; Jeffrey N Keen; Peter J F Henderson; Richard B Herbert
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

4.  Cysteine residues in the D-galactose-H+ symport protein of Escherichia coli: effects of mutagenesis on transport, reaction with N-ethylmaleimide and antibiotic binding.

Authors:  T P McDonald; P J Henderson
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

5.  NMR observation of substrate in the binding site of an active sugar-H+ symport protein in native membranes.

Authors:  P J Spooner; N G Rutherford; A Watts; P J Henderson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Proton-linked L-rhamnose transport, and its comparison with L-fucose transport in Enterobacteriaceae.

Authors:  J A Muiry; T C Gunn; T P McDonald; S A Bradley; C G Tate; P J Henderson
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Dissection of discrete kinetic events in the binding of antibiotics and substrates to the galactose-H+ symport protein, GalP, of Escherichia coli.

Authors:  P J Henderson; G E Martin; T P McDonald; A Steel; A R Walmsley
Journal:  Antonie Van Leeuwenhoek       Date:  1994       Impact factor: 2.271

8.  Unfolding free energy of a two-domain transmembrane sugar transport protein.

Authors:  Heather E Findlay; Nicholas G Rutherford; Peter J F Henderson; Paula J Booth
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.